In Other News

• Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

• Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer

• Proteomic Workflow Maps Microbial and Host Responses in Intestinal Inflammation

• Metagenomic Sequencing Enables Faster Diagnosis of Respiratory Infections in Cystic Fibrosis

• Genprex and Roche Collaborate on AI-Driven NSCLC Biomarker Testing

• New Genetic Cause Identified for Neurodevelopmental Disorder

• Collaboration Explores Clinical Use of Single-Cell and Spatial Technologies

• Machine Learning Tool Improves Prediction of Liver Cancer Recurrence

• Portable Molecular Platform to Advance Point-of-Care Testing for Lassa Fever

• New Genetic Discovery Could Support Precision Diabetes Care

• Study Highlights Need for Routine Hepatitis E Testing in Cirrhosis

• Portable Point-of-Care Molecular Test Detects Lassa Fever in Real Time

• Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care

• AI-Powered Liquid Biopsy Detects Liver Cancer Across Diverse Populations

• Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment

• Polygenic Risk Score Test Estimates Inherited Coronary Artery Disease Risk

• Partnership Brings Automated Pathology Archiving Solutions to U.S. Labs

• New Collaboration Integrates Low-Code Automation into Laboratory Platform

• Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results

• Blood Test Enters UK Primary Care Pathway for Earlier Alzheimer’s Diagnosis

• ADLM 2026 Unites Laboratory Experts Around Emerging Diagnostic Technologies

• Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment

• Kompass Diagnostics Wins 2026 ADLM Disruptive Technology Award for Rapid Multimodal Testing Platform